|
CDKAL1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62747593179802E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01039995761931E-09 |
| Normal-vs-Stage2 |
2.00529999999643E-05 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.39369999990957E-07 |
| Stage1-vs-Stage2 |
3.101000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.859400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
2.815600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72106773277392E-12 |
| Normal-vs-AfricanAmerican |
6.90030000027875E-07 |
| Normal-vs-Asian |
7.03139999558289E-08 |
| Caucasian-vs-AfricanAmerican |
4.598400E-01 |
| Caucasian-vs-Asian |
6.535600E-02 |
| AfricanAmerican-vs-Asian |
2.550400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42299999561502E-08 |
| Normal-vs-Female |
2.70450328798688E-11 |
| Male-vs-Female |
6.033600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.36069999999656E-05 |
| Normal-vs-Extreme_Weight |
1.37929999977082E-07 |
| Normal-vs-Obese |
1.93979998730498E-09 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.351200E-01 |
| Normal_Weight-vs-Obese |
2.939800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.698600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.69409999997805E-06 |
| Normal-vs-Age(41-60Yrs) |
1.71348999999932E-05 |
| Normal-vs-Age(61-80Yrs) |
1.1996958981797E-11 |
| Normal-vs-Age(81-100Yrs) |
2.39920000000282E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.722400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.610200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.250750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.382770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.388800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.790200E-01 |
| Normal-vs-Grade 3 |
6.305800E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
5.587800E-01 |
| Grade 2-vs-Grade 4 |
4.790200E-01 |
| Grade 3-vs-Grade 4 |
6.305800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.20676859802916E-13 |
| Normal-vs-N1 |
7.11549996701422E-09 |
| N0-vs-N1 |
8.112000E-01 |
|
|
